Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Ovarian Cancer × sargramostim × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 29 Leukemia 27 Lymphoma, Follicular 24 Melanoma 22 Lymphoma, Non-Hodgkin 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Multiple Myeloma 15 Lymphoma, Large B-Cell, Diffuse 15 Leukemia, Myeloid, Acute 14 Breast Neoplasms 14 Neuroblastoma 13 Lymphoma, Mantle-Cell 13 Lymphoma, Large-Cell, Immunoblastic 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Prostatic Neoplasms 11 Neoplasms, Plasma Cell 10 Burkitt Lymphoma 10 Neoplasm Metastasis 9 Myelodysplastic Syndromes 9 Lung Neoplasms 9 Hodgkin Disease 9 Glioblastoma 9 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Chronic-Phase 8 Carcinoma, Non-Small-Cell Lung 8 Gliosarcoma 7 Ovarian Neoplasms 6 Central Nervous System Neoplasms 6 Neoplasms 5

Interventions

Bevacizumab 2 stenoparib 1 senaparib 1 sargramostim 1 Saline Solution 1 Paclitaxel 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡